Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03387397 · ClinicalTrials.gov registry record

Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities

A clinical trial, sponsored by Northwell Health.

Completed
Registry status
170
Enrollment target

NCT03387397 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 170 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03387397 has completed, sponsored by Northwell Health.

COMPLETED
Registry status
170 participants
Enrollment target

Study Summary

The investigators propose to utilize quantitative and qualitative methodology to better understand the impact of multiple drug use (polypharmacy) on medication adherence as well as the driving forces behind differential adherence in people living with HIV (PLWH) with comorbidities. Since the clinical relevance of differential adherence to antiretroviral therapy (ART) medication has already been demonstrated and associated with virologic failure and a more rapid progression to AIDS and death, it is imperative to understand the driving forces behind differential adherence (selective drug taking) and its impact on treatment outcomes in PLWH with comorbidities. To this end, the investigators propose utilizing self-report adherence data and abstracted medical record data including pharmacy refills to assess medication adherence among PLWH with comorbidities. The information gained regarding patients' clinical outcomes as well as patients' reported treatment adherence, quality of life, beliefs about medications, and treatment satisfaction will provide the investigators with a comprehensive picture of what constitutes successful HIV treatment among those PLWH managing multiple medications. This is particularly important as non-successful treatment may result in low patient satisfaction, breach of patient-provider trust and reduced medication adherence.

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2017-12-12
Est. Completion 2023-09-27

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT03387397

The ClinicalTrials.gov registry entry for NCT03387397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03387397 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03387397 about?

NCT03387397 is a clinical study titled "Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities". The investigators propose to utilize quantitative and qualitative methodology to better understand the impact of multiple drug use (polypharmacy) on medication adherence as well as the driving forces behind differential adherence in people living with HIV (PLWH) with comorbidities. Since the clinica...

What is the current status of trial NCT03387397?

This trial is currently completed. The enrollment target is 170 participants. The study started on 2017-12-12. Estimated completion is 2023-09-27.

Who is sponsoring clinical trial NCT03387397?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.